• 한국식품저장유통학회지
• /
• 제20권1호
• /
• pp.1-6
• /
• 2013

본 실험은 Curcuma longa L.의 비만, 인슐린 저항성 효과에 대해 알아보기 위하여 C. longa 를 50% 에탄올로 추출물을 제조한 다음 실험동물을 통하여 알아보았다. 실험동물로는 정상동물인 SD계 랫트와 2형 당뇨 모델인 db/db 마우스를 사용하였고 식이로는 고지방식이(15%fat diet)를 사용하였고 C. longa는 식이에 넣어 제공하였다. SD rat 에서 체중, 총지방량은 1.5% 울금식이군이 대조군보다 유의적으로 감소하였다. 혈청에서 인슐린, HOMA-IR, TG는 1.5% 울금식이군이 대조군보다 유의적으로 감소하는 것을 관찰할 수 있었다. db/db 마우스에서 체중은 1.5% 울금식이군이 대조군보다 감소하는 경향을 보였으나 유의적이지는 않았고 총지방량은 1.5% 울금식이군이 대조군보다 유의적으로 감소하는 것을 관찰 할 수 있었다. 본 실험에서 공복 시 혈당은 2주마다 측정하였는데 1.5% 울금식이군이 대조군보다 유의적으로 감소하였고 hemoglobin A1c도 유의적으로 감소하는 것을 관찰 할 수 있었다. 공복 시 혈당과 hemoglobin의 유의적인 감소로 인하여 혈청에서 측정한 insulin, HOMA-IR이 감소하는 경향을 보인 것으로 사료된다. 이상의 결과로 보아 C. longa 추출물은 체중조절 및 혈당조절에 도움이 되는 천연약물로서의 기능성이 입증되었다고 사료된다.

• 한국식품과학회지
• /
• 제32권6호
• /
• pp.1418-1425
• /
• 2000

아가리쿠스 버섯(동결 건조, 온풍 건조)에서 추출한 ${\beta}-glucan$을 7주령의 db/db마우스에 5주간 음용수로 제공하고 식이섭취량 및 체중의 변화를 관찰하고 혈액내의 포도당, 인슐린, 당화 헤모글로빈, 소장의 glycosidase의 활성을 측정하고 중성지방농도, 혈중 지질조성을 측정하였으며 결과는 다음과 같다. db/db 마우스에서 Agari.F군과 Agari.H군은 식이섭취량에서 Control군보다 유의적으로 낮았고, 그에 따라 체중증가량도 낮았으며, 혈중 인슐린 농도와 당화헤모글로빈 농도는 Control군에 비해 Agari.F군, Agari.H군, Acarbose군이 유의적으로 낮은 수준이었다. 소장의 maltase, lactase, sucrase의 활성은 Control군에서 Lean군에 비해 세 효소의 활성이 매우 높게 관찰되었고, 시료투여군인 Agari.F군, Agari.H군은 maltase의 경우 proximal, middle 부위는 대조군보다 낮았고 distal 부위에서는 Agari.F군의 활성이 가장 높았다. Sucrase, lactase의 활성은 모든 부위에서 시료투여군이 Control군보다 낮은 수준이었다. 혈중 중성지방 농도는 Control군에 비해 Agari.F군, Agari.H군, Acarbose군은 유의적으로 낮은 수준이었다. 혈중 total cholesterol의 농도의 경우 Control군과 Agari.H군은 유의적인 차이가 없었지만 Agari.F군과 Acarbose군은 유의적으로 낮았다. 혈중 VLDL cholesterol의 경우는 Control군에 비해 Agari.F군, Agari.H군은 유의적으로 낮았고 Acarbose군은 유의적인 차이가 없었다. 혈중 LDL cholesterol의 농도는 Control군이 유의적으로 높았으며, Acarbose군이 가장 낮았다. 혈중 HDL cholesterol의 농도는 Agari.H군이 유의적으로 가장 높았고, Control군이 가장 낮았다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제25권4호
• /
• pp.281-296
• /
• 2021

The beneficial effects of hypoxic preconditioning are abolished in the diabetes. The present study was designed to investigate the protective effects and mechanisms of repeated episodes of whole body hypoxic preconditioning (WBHP) in db/db mice. The protective effects of preconditioning were explored on diabetes-induced vascular dysfunction, cognitive impairment and ischemia-reperfusion (IR)-induced increase in myocardial injury. Sixteen-week old db/db (diabetic) and C57BL/6 (non-diabetic) mice were employed. There was a significant impairment in cognitive function (Morris Water Maze test), endothelial function (acetylcholine-induced relaxation in aortic rings) and a significant increase in IR-induced heart injury (Langendorff apparatus) in db/db mice. WBHP stimulus was given by exposing mice to four alternate cycles of low (8%) and normal air O₂ for 10 min each. A single episode of WBHP failed to produce protection; however, two and three episodes of WBHP significantly produced beneficial effects on the heart, brain and blood vessels. There was a significant increase in the levels of brain-derived neurotrophic factor (BDNF) and nitric oxide (NO) in response to 3 episodes of WBHP. Moreover, pretreatment with the BDNF receptor, TrkB antagonist (ANA-12) and NO synthase inhibitor (L-NAME) attenuated the protective effects imparted by three episodes of WBHP. These pharmacological agents abolished WBHP-induced restoration of p-GSK-3β/GSK-3β ratio and Nrf2 levels in IR-subjected hearts. It is concluded that repeated episodes of WHBP attenuate cognitive impairment, vascular dysfunction and enhancement in IR-induced myocardial injury in diabetic mice be due to increase in NO and BDNF levels that may eventually activate GSK-3β and Nrf2 signaling pathway to confer protection.

• 약학회지
• /
• 제42권6호
• /
• pp.613-620
• /
• 1998

Antidiabetic activity of Mori folium ethanol soluble fraction (MFESF) was examined in db/db mice, which is a spontaneously hyperglycemic, hyperinsulinemic and obese animal model . 500 and 1000mg/kg dose for MFFSF (designated by SY 500 and SY 1000, respectively) and 5mg/kg dose for acarbose were administered for 6 weeks. Body weight gain, fasting and non-fasting serum glucose, glycated hemoglobin and triglyceride were all reduced dose dependently when compared between db/db control group and MFESF treated group. At 11th and 13th week after birth, MFESF increased an insulin secretion which may result in lowering serum glucose level. Total activities of sucrase and maltase in SY 500 treated group were decreased when compared to db/db control. On the other hand, those in SY 1000 and acarbose treated groups were increased. This result may suggest that proteins for sucrase and maltase were compensatorily induced due to significant inhibition of glycosidase-catalyzed reaction at doses administered in this study.

• 대한한방내과학회지
• /
• 제35권1호
• /
• pp.70-78
• /
• 2014

Objectives : Hoechunyanggyeok-san (HYS) is a traditional herbal medicine, which has been clinically used for treating febrile and inflammatory diseases. HYS has been reported to be a useful treatment for diabetes, atherosclerosis and hyperlipidemia in the type 1 diabetic model. However, the mechanism of the effects of HYS against hyperglycemia and hyperlipidemia is poorly understood. In the present study, we investigated the underlying mechanism of ameliorative effect of HYS on hyperglycemia and hyperlipidemia in vivo. Methods : HYS (10, 50 mg/kg/day, p.o.) was administered every day for 2 weeks to db/db mice and its effect was compared with vehicle-treated db/db mice. To confirm serum glucose and triglyceride (TG) changes, serological testing was performed. The levels of sterol regulatory element-binding protein-1 (SREBP-1) activity and Sirtuin1 (SIRT1), AMP-activated protein kinase (AMPK), and acetyl-CoA carboxylase ${\alpha}$ ($ACC{\alpha}$) expression were analyzed by western blot analysis. Results : The administration of HYS significantly decreased the elevated serum glucose and TG in db/db mice. HYS administration increased the levels of SIRT1 and AMPK expression compared with the vehicle-treated group. Moreover, HYS treatment significantly inhibited SREBP-1 activity and $ACC{\alpha}$ expression in the liver, while the vehicle-treated group exhibited their increase. Conclusions : In conclusion, HYS is suggested to have an improvement effect on hyperglycemia and hyperlipidemia by activating the SIRT1/AMPK signaling pathway and inhibiting SREBP-1.

• 동의생리병리학회지
• /
• 제17권3호
• /
• pp.759-764
• /
• 2003

This study was carried out to understand the effects Of Bambusae Caulis in Liquamen and Silk Worm powder on blood sugar in the db/db mice. Refined Bambusae Caulis in LiquamenD(BCL,D)manufactured by high temperature production process and Silk Worm Powder were used. The Bambusae Caulis in Liquamen extracted from bamboo charcoal manufacturing process was filtered and refined. The effects of BCL.D + Silk Worm Powder and BCL.D were observed in terms of blood sugar, creatinine, BUN, GPT and histological examination of pancreatic tissue in db/db mice. The results were as follows : The amount of glucose was slightly decreased (P < 0.05) in the B CL.D+SWP groups compared with the control. The amount of glucose was significantly decreased (P < 0.01) in the BCL.D groups compared with the control. The amount of Creatinine did not show any differences among three groups. The amount of blood urea nitrogen observed significant decrease in the case of BCL.D groups. The amount of GPT did not show any differences among three groups. The intense of insulin-immunoreactivity of β cells showed the strongest in the normal group, and more strong in the BCL.D+SWP group compared with control group.

• Food Science and Biotechnology
• /
• 제17권6호
• /
• pp.1228-1234
• /
• 2008

Having idea to develop more effective anti-diabetic agent from ginseng root, we comprehensively assessed the anti-diabetic activity and mechanisms of ginsam in C57BL/KsJ db/db mice. The db/db mice were divided into 4 groups; diabetic control (DC), ginsam at a dose of 300 or 500 mg/kg (GS300 or GS500) and metformin at a dose of 300 mg/kg (MT300). Ginsam was orally administered for 8 weeks. GS500 reduced the blood glucose concentration and significantly decreased an insulin resistance index. In addition, GS500 reduced the plasma non-esterified fatty acid, triglyceride, and increased high density lipoprotein-cholesterol as well as decreased the hepatic cholesterol and triglyceride. More interestingly, ginsam increased the plasma adiponectin level by 17% compared to diabetic control group. Microarray, quantitative-polymerase chain reaction and enzyme activity results showed that gene and protein expressions associated with glycolysis, gluconeogenesis, and fatty acid oxidation were changed to the way of reducing hepatic glucose production, insulin resistance and enhancing fatty acid $\beta$-oxidation. Ginsam also increased the phosphorylation of AMP-activated protein kinase and glucose transporter expressions in the liver and skeletal muscle, respectively. These changes in gene expression were considered to be the mechanism by which the ginsam exerted the anti-diabetic and anti-dyslipidemic activities in C57BL/KsJ db/db mice.

• 약학회지
• /
• 제50권6호
• /
• pp.345-350
• /
• 2006

The pharmacological properties of ginseng are mainly attributed to ginsenosides, the active constituents that are found in the extracts of different species of ginseng. Lately; the studies on ginsenosides are mainly focused on IH-901, a major intestinal bacterial metabolite of ginsenosides. In this study; we examined the anti-diabetic activity of IH-901 in C57BU61 db/db mice model. IH-901 was administrated orally at a dose of 20 mg/kg for 5 weeks. During the experimental period, body weight and blood glucose levels were measured every week. After 5 weeks, db/db mice were sacrificed and diabetic parameters were analyzed. IH-901 treated group showed a significant decrease in fasting blood glucose levels (from 10.5 mM to 9.4 mM), insulin resistance index (from 163.6 to 100.2) and triglyceride levels (from 115.3 to 70.1) compared to the diabetic control. In Pancreatic islets morphology; IH-901 treated group revealed much less infltrated mononuclear cells, indicating that IH-901 recovered ${\beta}$-cell damage due to hyperglycemia. In addition, IH-901 upregulated expressions of glucose transporter 4 (GLUT4) and PPAR-${\gamma}$ in skeletal muscle and adipose tissue, respectively. Taken together IH-901might be a potential anti-hyperglycemic agent with insulin sensitizing effect.

• Journal of Applied Biological Chemistry
• /
• 제62권4호
• /
• pp.417-424
• /
• 2019

이 연구의 목적은 당 대사에 대한 삼색싸리(Lespedeza maximowiczii var. tricolor Nakai; LMTN)의 효과를 조사하는 것이다. LMTN 추출물은 대조군과 비교하여 3T3-L1 지방 세포에서 당 섭취능 및 지질축적을 유의하게 향상시켰다. 또한, 3T3-L1 지방 세포에서 LMTN 추출물은 퍼옥시좀 증식제 활성화 수용체(PPAR)γ, 인슐린수용체기질-1 (IRS-1) 및 포도당수송체(GLUT)4의 단백질 발현을 유의하게 증가시켰다. LMTM 추출물의 당 섭취능 또는 인슐린 신호 전달계의 조절 효과는 양성 대조물질인 트로글리타존 또는 피니톨보다 낮았지만 PPARγ 단백 활성화는 증가하였다. 또한, LMTM 추출물은 인슐린 유사효과를 나타냈다. db/db 마우스에서, LMTN 추출물(250 mg/kg BW)은 물과 식이 섭취량, 혈당, 중성지방과 총 콜레스테롤 함량을 유의적으로 감소시켰다. 더불어 지방과 근육조직에서의 PPARγ 및 GLUT4 mRNA의 발현도 LMTN 추출물 투여군에서 유의적으로 증가되었다. 따라서, 본 연구의 결과는 LMTN 추출물이 3T3-L1 지방세포 및 db/db 마우스에서 PPARγ 및 인슐린 유사효과를 통해 당 대사를 조절하는 것으로 밝혀졌다.

• Nutrition Research and Practice
• /
• 제12권6호
• /
• pp.469-478
• /
• 2018

BACKGROUND/OBJECTIVES: Mulberry leaf (ML) has been shown to have an inhibitory effect on ${\alpha}$-glucosidase, and suppresses postprandial hyperglycemia, which may be related to its deoxynojirimycin (DNJ) content. This study was conducted to investigate the hypoglycemic and dyslipidemic effects of rice coated with ML rich in DNJ in a type 2 diabetes mouse model. MATERIALS/METHODS: The mice were divided into four groups (n = 8 each): non-diabetic normal control (NC); diabetic control (DM-C), fed with 10% polished rice powder (DM-R); and fed with 10% polished rice powder coated with DNJ-rich ML (DM-DNJR). RESULTS: Supplementation with DNJR for six weeks decreased levels of fasting blood glucose, plasma insulin, triglyceride, total cholesterol, and blood glycosylated hemoglobin; conversely, levels of glucagon-like peptide-1 and high-density lipoprotein-cholesterol showed an increase in the same treatment. In addition, weights of mesenteric, epididymal, and total adipose tissues decreased with DNJR supplementation, when compared with diabetic control db/db mice, while maltase, lactase, and sucrase activity in the small intestine were inhibited. The anti-diabetic effects were marginally greater in the DM-DNJR group than in the DM-R group. CONCLUSIONS: These results suggest that rice coated with ML rich in DNJ can reduce hyperglycemia and hyperlipidemia in db/db mice, and may prove useful for individuals with diabetes.